Moderna Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. My name is Jessica Fye, large-cap biotech analyst at JPMorgan, and we're continuing the 44th Annual JPMorgan Healthcare Conference today with Moderna. First, you're going to hear a presentation about the company, and then we're going to go into some Q&A. So if you're in the room and you raise your hand, someone will bring you a microphone or alternatively, if you're listening on the webcast, you can submit questions on the portal and I can read them off the iPad up here.
So with that, let me pass it over to Moderna's CEO, Stéphane Bancel.
Thank you, Jessica. Good afternoon, and welcome to Moderna's presentation at this year's JPMorgan conference. Let me start by reminding you that we're going to be making forward-looking statements. You can find those on our website or on the SEC website. What we're working with the team to do in the next few years is basically to build a respiratory vaccine franchise to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
